Authors: Everett, SA Naylor, MA Barraja, P Swann, E Patel, KB Stratford, MRL Hudnott, AR Vojnovic, B Locke, RJ Wardman, P Moody, CJ

Citation: Sa. Everett et al., Controlling the rates of reductively-activated elimination from the (indol-3-yl)methyl position of indolequinones, J CHEM S P2, (5), 2001, pp. 843-860

Authors: Faig, M Bianchet, MA Winski, S Hargreaves, R Moody, CJ Hudnott, AR Ross, D Amzel, LM

Citation: M. Faig et al., Structure-based development of anticancer drugs: Complexes of NAD(P)H : quinone oxidoreductase 1 with chemotherapeutic quinones, STRUCTURE, 9(8), 2001, pp. 659-667

Authors: Swann, E Barraja, P Oberlander, AM Gardipee, WT Hudnott, AR Beall, HD Moody, CJ

Citation: E. Swann et al., Indolequinone antitumor agents: Correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H : quinone oxidoreductase. Part 2, J MED CHEM, 44(20), 2001, pp. 3311-3319